ACMR vs EXAS · P/E 76, rev $524.2M vs rev $2.76B
Acm Research Inc (ACMR) versus EXACT Sciences Corporation (EXAS) — a side-by-side from cached financials, not a winner call.
Acm Research Inc (ACMR) is a semiconductor equipment & materials company listed on NASDAQ.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Latest reported ACMR revenue for 2026-06-30 was $524.2M. Net income was $106.3M. ACMR currently screens at market cap $6.86B and trailing P/E 75.7.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
ACMR currently screens at market cap $6.86B and trailing P/E 75.7. EXAS currently screens at market cap $20.03B.
Not investment advice. Open the ACMR and EXAS stock pages for the full models.
Not investment advice.